Compounds of formula (I), wherein X and R
1
-R
6
, are as defined in the claims, exhibit alpha2 agonistic activity and thus are useful as alpha2 agonists, especially as alpha2A agonists. Methods of use of said compounds are also provided.
[EN] NEW ALPHA2 ADRENOCEPTOR AGONISTS<br/>[FR] NOUVEAUX AGONISTES DU RÉCEPTEUR ADRÉNERGIQUE ALPHA2
申请人:ORION CORP
公开号:WO2013150173A1
公开(公告)日:2013-10-10
Compounds of formula (I), wherein X and R1-R6, are as defined in the claims, exhibit alpha2 agonistic activity and thus useful as alpha2 agonists, especially as alpha2A agonists. Methods of use of said compounds are also provided.